A reduction in serum glucocorticoids provokes experimental allergic encephalomyelitis

Glucocorticoid (GCC) therapy usually inhibits inflammatory diseases, but certain regimens can trigger relapses. Clinical use of steroids is not uniform and in some instances may be dangerous. In the present study, GCCs modified the course of experimental allergic encephalomyelitis (EAE) in Lewis rats, a model of inflammatory CNS disease. Continuous treatment with dexamethasone (DEX) completely blocked EAE. RU 486, a GCC antagonist, counteracted the effects of endogenous GCCs and worsened EAE. Sudden withdrawal of DEX also caused severe clinical and histologic exacerbations at a time when paired saline-treated animals had completely recovered. In rats that had complete clinical recovery from EAE, and would not have relapsed without this acute steroid deficit, a short pulse of DEX was followed by severe exacerbations. In contrast, a slow steroid taper prevented exacerbations. Abrupt discontinuation of GCCs provokes inflammatory brain disease.

[1]  A. Reder,et al.  Adrenal size is increased in multiple sclerosis. , 1994, Archives of neurology.

[2]  S. Reingold,et al.  Megadose corticosteroids in multiple sclerosis , 1994, Neurology.

[3]  R. Beck,et al.  The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group. , 1993, The New England journal of medicine.

[4]  T. Crawford,et al.  Cerebral white matter changes in acquired immunodeficiency syndrome dementia: Alterations of the blood‐brain barrier , 1993, Annals of neurology.

[5]  H. Weiner,et al.  Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain , 1992, The Journal of experimental medicine.

[6]  K. Mohler,et al.  Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. , 1992, Journal of immunology.

[7]  D. Mason.  T-cell subsets in experimental allergic encephalomyelitis: interactions between the immune and neuroendocrine systems in the regulation of their activity. , 1992, Chemical immunology.

[8]  W. Karpus,et al.  CD4+ suppressor cells of autoimmune encephalomyelitis respond to T cell receptor‐associated determinants on effector cells by interleukin‐4 secretion , 1992, European journal of immunology.

[9]  A. Thompson,et al.  High dose steroids in acute relapses of multiple sclerosis: MRI evidence for a possible mechanism of therapeutic effect. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[10]  Neil R. Miller,et al.  A Randomized, Controlled Trial of Corticosteroids in the Treatment of Acute Optic Neuritis , 1992 .

[11]  S. Jimenez,et al.  Regulation of transforming growth factor-beta 1 gene expression by glucocorticoids in normal human T lymphocytes. , 1991, The Journal of clinical investigation.

[12]  A. Reder,et al.  Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis , 1991, Journal of Neuroimmunology.

[13]  R. Clark,et al.  An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis , 1990, The Journal of experimental medicine.

[14]  D. Mason,et al.  The role of the neuroendocrine system in determining genetic susceptibility to experimental allergic encephalomyelitis in the rat. , 1990, Immunology.

[15]  Y. Herishanu,et al.  A possible harmful late effect of methylprednisolone therapy on a time cluster of optic neuritis , 1989, Acta neurologica Scandinavica.

[16]  R. Daynes,et al.  Contrasting effects of glucocorticoids on the capacity of T cells to produce the growth factors interleukin 2 and interleukin 4 , 1989, European journal of immunology.

[17]  R. Renkonen.  Regulation of Intercellular Adhesion Molecule‐1 Expression on Endothelial Cells with Correlation to Lymphocyte‐Endothelial Binding , 1989, Scandinavian journal of immunology.

[18]  G. Chrousos,et al.  A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[19]  D. Mason,et al.  Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids , 1989, The Journal of experimental medicine.

[20]  W. Buchanan,et al.  Are 'homeopathic' doses of oral corticosteroids effective in rheumatoid arthritis? , 1988, Clinical and experimental rheumatology.

[21]  K. Selmaj,et al.  Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro , 1988, Annals of neurology.

[22]  S. Cook,et al.  Steroid therapy in multiple sclerosis. Point of view. , 1987, Archives of neurology.

[23]  H. Meltzer,et al.  Dexamethasone suppression test abnormalities in multiple sclerosis , 1987, Neurology.

[24]  R. Brady,et al.  Elevated neutral protease activity in myelin from brains of patients with multiple sclerosis , 1984, Annals of neurology.

[25]  J. Blalock,et al.  Virus-induced corticosterone in hypophysectomized mice: a possible lymphoid adrenal axis. , 1982, Science.

[26]  E. Unanue,et al.  Corticosteroids inhibit murine macrophage Ia expression and interleukin 1 production. , 1982, Journal of immunology.

[27]  J. Cox,et al.  The migration of lymphocytes across specialized vascular endothelium. IV. Prednisolone acts at several points on the recirculation pathways of lymphocytes. , 1982, Cellular immunology.

[28]  R. Swanborg,et al.  Autoimmune effector cells: I. Transfer of experimental allergic encephalomyelitis with lymphoid cells cultured with antigen , 1980 .

[29]  J. Trotter,et al.  Prolonged effects of large‐dose methylprednisolone infusion in multiple sclerosis , 1980, Neurology.

[30]  H. Claman.  Corticosteroids and lymphoid cells. , 1972, The New England journal of medicine.

[31]  N. Geschwind,et al.  Cooperative study in the evaluation of therapy in multiple sclerosis , 1970, Neurology.

[32]  D. Ziegler.  Acute disseminated encephalitis. Some therapeutic and diagnostic considerations. , 1966, Archives of neurology.

[33]  R. Kibler.  LARGE DOSE CORTICOSTEROID THERAPY OF EXPERIMENTAL AND HUMAN DEMYELINATING DISEASES * , 1965, Annals of the New York Academy of Sciences.

[34]  S. Levine,et al.  Enhancement of Experimental Allergic Encephalomyelitis by Adrenalectomy.∗ , 1962, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[35]  S. Levine,et al.  Suppression of Experimental Allergic Encephalomyelitis by Stress.∗ , 1962, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[36]  R. Flower,et al.  The effects of the anti-glucocorticoid RU 38486 on steroid-mediated suppression of experimental allergic encephalomyelitis (EAE) in the Lewis rat. , 1989, Life sciences.

[37]  G. Chrousos,et al.  Increased adrenocorticotropin, cortisol, and arginine vasopressin secretion in primates after the antiglucocorticoid steroid RU 486: dose response relationships. , 1985, The Journal of clinical endocrinology and metabolism.